A new study found that A&E patients with visible blood in their urine who receive a scan within 48 hours are 2.5% less likely to die within three months. The study also showed that patients with cancer are diagnosed significantly faster when they receive prompt investigation.
Researchers compare prostate cancer screening to breast cancer screening, finding similarities in identifying significant cancers and reducing mortality. The study suggests that prostate cancer screening should be reconsidered, offering benefits over harms, and highlights the need for further analysis on costs.
A new smartphone app has been shown to significantly improve sex life and delay ejaculation in men with premature ejaculation. The app, developed by urologists and psychologists, teaches men therapeutic techniques and exercises to manage arousal and control ejaculation.
A new imaging test, PSMA PET/CT scan, has been shown to safely reduce the number of biopsies needed for suspected prostate cancer, with no harm to patients. The PRIMARY2 trial found that the scan could identify low-risk patients who did not need a biopsy, while targeting suspicious areas for those who did.
A new study suggests that using virtual reality (VR) to explain medical procedures can help patients better understand their treatment and reduce anxiety. The research tested VR as part of the consent process for a procedure to treat kidney stones, with patients reporting improved understanding and reduced anxiety after the experience.
Research presented at EAU26 confirms that prostate cancer screening leads to a reduction in mortality, but also detects cancers that would otherwise remain undetected. The study's findings suggest that using MRI in prostate cancer screening can reduce overdiagnosis and unnecessary biopsies.
A new international study found that 35% of respondents couldn't define cystitis correctly, highlighting the need for public education on UTIs amid rising antibiotic resistance. Women are significantly more affected by UTIs, but awareness is lower among men and younger adults.
A new surgical technique called NeuroSAFE has been shown to preserve erectile function in men with prostate cancer, with 39% of patients experiencing no or mild dysfunction after treatment. This is compared to 23% of those who received standard surgery.
A simple urine test has shown promising results in detecting early-stage kidney cancer recurrence, with a high sensitivity and specificity rate. The GAGome test can accurately identify patients at risk of recurrence, potentially reducing the need for invasive scans and enabling faster treatment access.
A new study has shown that high-resolution ultrasound can diagnose prostate cancer as effectively as MRI, with improved resolution and lower costs. The technology, called micro-ultrasound, is expected to speed up diagnosis, reduce hospital visits, and make imaging more accessible, particularly in less developed healthcare systems.
A TB vaccination has been shown to boost the immune system of bladder cancer patients, reducing cancer recurrence rates by up to 75% in a small pilot study. The vaccine was well-tolerated with no side effects and showed promising results in improving patient outcomes.
A new study shows that comprehensive clinical assessments (CCAs) are equally effective to guiding treatment for women with overactive bladder or urinary incontinence, avoiding invasive urodynamics testing. CCA includes a medical questionnaire, physical examination, and tests such as urinalysis, revealing similar patient-reported outcom...
The WATER III trial shows that waterjet surgery can better preserve ejaculation function compared to standard laser surgery. The technique has similar outcomes and can be performed with robot assistance, reducing waiting times for men with urinary problems caused by an enlarged prostate.
A sub-analysis of 20-year follow-up data from the European Randomized study of Screening for Prostate Cancer (ERSPC) reveals that men who consistently decline prostate cancer screening appointments have a 45% higher risk of dying from the disease compared to those who attend screening appointments.
A wearable t-shirt with sensors monitors vital signs and detects complications, allowing patients to be discharged 24-36 hours earlier than control group. The device also improved patient satisfaction and quality of life.
A new study found that combining pelvic floor exercises with behavioral therapy can be more effective than current medical treatments in helping men with frequent urges to urinate. The Bladder Emptying Disorder Therapy (BEST) Trial showed significant improvements in symptoms and quality of life measures after just 12 weeks.
A new oral vaccine for recurrent Urinary Tract Infections (UTIs) has been shown to prevent infections in over half of participants for up to nine years. The MV140 vaccine was found to be safe and effective, with no notable side effects reported.
A simple urine test can reduce the number of cystoscopies required to follow up high-risk bladder cancer patients by more than half. The test monitors for recurrence of bladder cancer by measuring levels of five target mRNAs and was found to be effective in picking up cancer recurrence before any disease was visible through a cystoscopy.
A simple blood test every five years is sufficient to screen low-risk men for prostate cancer, according to new research. Researchers found that only 0.13% of men with low PSA levels developed cancer after a decade.
Recent trials have shown that testing for tumour DNA in the blood can identify advanced bladder cancer patients who are less likely to relapse after surgery, allowing doctors to target treatments more effectively.
A new technique involving a small flap in the peritoneum can reduce postoperative complications in prostate cancer surgery by allowing lymphatic fluid to escape and be absorbed. The study found that this technique significantly reduced the incidence of lymphocele, a common complication where lymphatic fluid collects in the pelvis.
The ProtecT trial found that active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery. Men on active monitoring were more likely to see their cancer progress, but this didn't reduce their likelihood of survival.
A UK study reviewing over 90,000 vasectomies found that chronic scrotal pain occurs in just 0.2% of patients, while post-operative infection rates are around 1.6%. The study updates outdated figures and aims to encourage more men to undergo the procedure.
A study published by the European Association of Urology defines 'growers' and 'showers' as men whose penises increase in size by more than 56% when erect, compared to flaccid states. The researchers found that most men fell into a 'grey zone', with only 24% classified as growers and 25% as showers.
A survey of over 1000 patients found that two thirds prefer a urologist of their own gender, but in certain situations, both men and women choose a female doctor. Patients with painful conditions are more likely to opt for a female urologist.
A new urine gene test can detect genetic mutations in urine that predict bladder cancer up to 12 years in advance of clinical symptoms. The test was trialled on over 50,000 participants and showed promising results, suggesting its potential for early detection and reduced unnecessary invasive procedures.
A trial using PSMA-PET/CT scans has shown that clinicians changed their treatment plans for patients with clinically significant prostate cancer in 19% of cases, helping to detect more cancers. The technique was found to be beneficial in high-risk patients but also led to false positives requiring further investigations.
A new study suggests that digital rectal examination (DRE) is not a reliable screening tool for early prostate cancer detection. Researchers found that DRE missed many cancers in their early stages, with only 3 out of 57 suspicious cases detected. This method was compared to PSA testing, which detected four times more prostate cancers.
The European Association of Urology warns that bladder cancer is often overlooked due to lack of awareness. A new survey found that over half of adults do not recognize common symptoms such as changes in urine color, leading to delayed diagnosis and poorer treatment outcomes.
New research suggests that closely monitoring low-risk prostate cancer can be as effective as active treatment in reducing mortality rates and preserving sexual function. This approach allows men to live with the disease for ten years or more without treatment, while still being unlikely to die from it.
A new study found that using an existing immunotherapy drug for late-stage kidney cancer at an earlier stage can reduce the risk of cancer returning by a third. The KEYNOTE study involved over 1000 patients and showed similar side effects to other cancer treatments.
A phase 3 trial found that Lu-PSMA-617 significantly improved survival and progression-free survival of patients with metastatic castration-resistant prostate cancer. The treatment delivered beta radiation directly to tumour cells, keeping them alive for longer than standard care.
A new study found that obese patients with advanced prostate cancer survive longer than their overweight and normal-weight counterparts. Obesity was associated with a 10% higher survival rate over 36 months. The 'obesity paradox' suggests that high body mass index may be protective in certain cases.
A new study found that a stunning virtual reality setting can reduce pain caused by uncomfortable medical procedures, such as cystoscopies. The research used VR headsets to present patients with a calming Icelandic landscape, resulting in lower pain scores and reduced anxiety.
A new study found that supplementing testosterone significantly reduces heart attacks and strokes in men with unnaturally low hormone levels. The 10-year study involved over 800 men from Germany and Qatar, showing a 25% reduction in risk for those under 55 and a 15% reduction for those over 60.
A pilot study found that patients with high cotinine levels were four times more likely to have their cancer return. The researchers aim to develop a simple urine test for cotinine to reduce invasive investigations for bladder cancer patients.
Research reveals that women with urinary incontinence are more likely to experience depression, lower self-worth, and poorer mental health outcomes. The study emphasizes the importance of discussing mental health with patients undergoing treatment.
Research shows that men with symptomatic Covid-19 and low testosterone are more likely to become severely ill and die. The lower the testosterone levels, the higher the likelihood of severe illness and death, according to a study presented at the European Association of Urology congress.
A European survey found that a majority of men and women aged 20-70 do not know what erectile dysfunction (ED) is, with one in four having never heard of ED treatments. The study emphasizes the need for open communication about ED to break the taboo and improve treatment outcomes.
A global methodology has been developed to help decide when to treat prostate cancer, providing a single standard for estimating tumour aggressiveness. The GAP3 consortium's analysis of 14,380 patients reveals that certain factors can predict cancer development, enabling more informed treatment decisions.
Researchers found that men are now more likely to visit clinics for Peyronie's disease and low sexual desire, while erectile dysfunction cases have declined. The study suggests a growing awareness of these conditions, possibly driven by increased openness and access to treatments.
A study found that women taking MHT have a greater variety of beneficial bacteria in their urine, potentially creating conditions that discourage urinary infections. The study also showed that women with recurrent UTIs have fewer types of bacteria in their urine.
A major study conducted by patients themselves reports significant numbers struggling with continence and sexual problems after prostate cancer treatment. The Europa Uomo Patient Reported Outcomes Study found that any treatment apart from active surveillance negatively affects quality of life.
Researchers found the AZIN1 gene associated with metastatic prostate cancer, with reduced expression leading to fewer metastases. Further investigation is needed to confirm findings in all prostate cancers.
A study of 3267 men found that watching porn is associated with greater erectile dysfunction and lower satisfaction with sex. The research suggests that the type of porn watched may contribute to impaired erectile function, with 23% of men under-35 experiencing some level of erectile dysfunction.
Scientists have identified two coffee compounds, kahweol acetate and cafestol, which inhibit the growth of prostate cancer cells in cell culture and animal models. The study's findings suggest that these compounds may be used to treat drug-resistant prostate cancer, with further investigation needed.
Men undergoing hormonal treatment after prostate removal are 80% more likely to suffer from depression, according to a study presented at the European Association of Urology congress. The treatment is given to control tumor growth, but it may also affect men's well-being.
A new study reveals that patients with prostate, bladder, or kidney cancers who have had psychiatric care prior to treatment are at a greater risk of dying. The research also found an increased suicide risk among these patients, even after adjusting for previous mental health treatment.
Researchers have discovered that sperm DNA taken directly from the testicles of infertile men is as good as that of ejaculated sperm from fertile men, potentially opening a new way for treatment. This finding may explain a major cause of male infertility and could lead to improved fertility outcomes.
Researchers have found that testosterone replacement therapy reduces prostate cancer recurrence in low-risk patients by nearly three-fold over three years. This study challenges the long-held notion that testosterone promotes prostate cancer and suggests a potential new treatment approach for these patients.